信維通信(300136.SZ):擬以1億元轉讓德清華瑩2.2222%股權予瑞業專精
格隆匯7月28日丨信維通信(300136.SZ)公佈,公司於2022年7月28日召開第五屆董事會第二次會議審議通過了《關於擬轉讓參股公司部分股權的議案》,同意公司以1億元的價格將持有的中電科技德清華瑩電子有限公司(“德清華瑩”或“目標公司”)2.2222%股權轉讓給淄博瑞業專精四期投資合夥企業(有限合夥)(“瑞業專精”),同時授權公司管理層按照市場原則,以詢價、洽談等方式尋找意向方,通過分批次或者整體轉讓的方式繼續轉讓公司持有德清華瑩不超過3.3333%股權,並授權公司管理層負責董事會權限範圍內此次相關交易的具體實施及法律文件、協議的簽署。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.